Panbela Therapeutics, Inc.
PBLADelisted Apr 25, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001029125
Panbela Therapeutics, Inc. was delisted on Apr 25, 2024; its insiders filed their last Form 4 on Nov 19, 2024; 11 institutions reported holding it in 13F filings for Q4 2023, worth $115.8K in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Panbela Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 13 | 17 | +4 |
| Shares | 171.4K | 2.97M | +2.80M (+1,634.0%) |
| Value | $111.0K | $801.0K | +$690.0K (+621.6%) |
New holders (7)
Institutions that held Panbela Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Armistice Capital, LLC | 2,176,809 | $588.0K | 0.01% |
| Vanguard Group Inc | 222,303 | $60.0K | 0.00% |
| Clear Street LLC | 110,500 | $30.0K | 0.00% |
| Virtu Financial LLC | 71,759 | $19.0K | 0.00% |
| Oxford Financial Group Ltd | 20,000 | $5.00K | 0.00% |
| Verition Fund Management LLC | 20,001 | $5.00K | 0.00% |
| Bank of America Corp | 2,857 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Panbela Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Susquehanna International Group, LLP | 18,540 | $12.0K |
| Ergoteles LLC | 16,000 | $11.0K |
| Citadel Advisors LLC | 10,793 | $7.00K |